About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
19th Conference of the International Society of Geriatric Oncology
www.siogconference.org
Breast
Hematologic Oncology
Lung
Business
General Oncology
Palliative Care
Gastrointestinal
Genitourinary
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
H
(Neo)Adjuvant Approach to HER2+ Breast Cancer in Older Adults: De-escalation Strategies (Taxane Only Regimens, Shorter Duration Trastuzumab, Anti-HER2 Without Chemo, etc.)
By
19th Conference of the International Society of Geriatric Oncology
FEATURING
Hans Wildiers
By
19th Conference of the International Society of Geriatric Oncology
FEATURING
Hans Wildiers
880 views
December 24, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
23:14
AstraZeneca Oncology
Management Strategies for Nausea and Vomiting in First-line Maintena…
Feat.
D. Czel,
C. Arn
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
Breast
02:46
19th Conference of the International Society of Geriatric Oncology
The Prevalence of Luminal B Subtype Is Higher in Older Postmenopausa…
Feat.
M. Mills
03:10
19th Conference of the International Society of Geriatric Oncology
Cytoplasmic Cyclin E Is an Exquisite Marker of Tumour Biology in Old…
Feat.
R. Parks
03:02
19th Conference of the International Society of Geriatric Oncology
79 y/o Female w/ HER+ Breast Cancer: Questions on (Neo)Adjuvant Chem…
Feat.
E. Perez De Celis
08:33
19th Conference of the International Society of Geriatric Oncology
(Neo)Adjuvant Approach to HER2+ Breast Cancer in Older Adults: De-es…
Feat.
H. Wildiers
09:47
19th Conference of the International Society of Geriatric Oncology
Radiation Therapy in HER+ Breast Cancer: Relative Benefits Are Const…
Feat.
R. Simcock
02:56
19th Conference of the International Society of Geriatric Oncology
89 y/o Female w/ TNBC: Questions on (Neo)Adjuvant Chemo, Radiation T…
Feat.
E. Perez De Celis
09:44
19th Conference of the International Society of Geriatric Oncology
Breast Cancer Surgery Impacts on Functional Status and Independence,…
Feat.
R. Parks
09:33
19th Conference of the International Society of Geriatric Oncology
Chemo Regimens in Older Adults w/ TNBC: Sequential Anthracycline / T…
Feat.
N. Battisti
03:40
19th Conference of the International Society of Geriatric Oncology
Serious Adverse Events Among Older Patients in the ALTTO Trial Compa…
Feat.
L. Dal Lago
